About Maurizio Cereda, MD
Maurizio Cereda, MD, is a practicing anesthesiologist and intensive care physician. He trained at the University of Milan in Italy, at the National Institutes of Health (NIH), at the University of North Carolina—Chapel Hill and at the University of Pennsylvania. He was a faculty member at the University of Pennsylvania from 2004-2022.
His clinical focus is caring for patients who are critically ill and at higher risk for surgical complications. Dr. Cereda is an independent investigator with an academic interest in acute respiratory failure, lung imaging and mechanical ventilation.
Clinical Interests:
- Acute Respiratory Failure
- Anesthesia for abdominal surgery
- Anesthesia for bariatric surgery
- Intensive Care Medicine
- Mechanical ventilation
- Shock
Treats:
- Adult
Languages:
- French, Italian
Locations
Mass General Anesthesia and Pain Medicine
55 Fruit St.
Boston, MA 02114
Phone: 617-726-3030
Medical Education
- MD, Universita Degli Studi Di Milano
- Residency, University of North Carolina Hospitals
- Fellowship, Hospital of the University of Pennsylvania
American Board Certifications
- Anesthesiology, American Board of Anesthesiology
- Critical Care Medicine, American Board of Anesthesiology
Accepted Insurance Plans
- Aetna
- Beech Street
- Blue Cross Blue Shield
- Blue Cross Blue Shield Medicare
- Cigna
- Commonwealth Care Alliance
- Coventry
- Fallon Health
- Harvard Pilgrim Health Care
- Humana
- Maine Community Health Options
- Mass General Brigham Health Plan
- MassHealth
- Medicaid CT
- Medicaid ME
- Medicaid NH
- Medicaid RI
- Medicaid VT
- Medicare
- Medicare ACO
- Multiplan
- Railroad Medicare
- Senior Whole Health
- TriCare
- Tufts Health Plan
- Unicare
- United Health Care
- WellSense
- WellSense NH
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Research
Dr. Cereda?s NIH-funded research is focused on acute respiratory distress syndrome (ARDS). His long-term goal as researcher is to understand and address the mechanisms that lead to established ARDS through dissemination of early injury to the lungs. For this reason, Dr. Cereda?s research aims to identify novel imaging predictors of ARDS progression, using quantitative computed tomography and hyperpolarized gas magnetic resonance imaging. His group is now investigating the role of abnormal pulmonary perfusion in the progression of lung injury, and exploring pharmacological protection of the endothelium to slow such evolution.